Literature DB >> 27241581

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.

Carmine Pinto1, Maria Angela Bella2, Ettore Capoluongo3, Paola Carrera4, Claudio Clemente5, Nicoletta Colombo6, Laura Cortesi7, Gaetano De Rosa8, Francesca Fenizia9, Maurizio Genuardi10, Stefania Gori11, Valentina Guarneri12, Antonio Marchetti13, Paolo Marchetti14, Nicola Normanno15, Barbara Pasini16, Sandro Pignata17, Paolo Radice18, Enrico Ricevuto19, Antonio Russo20, Pierosandro Tagliaferri21, Pierfrancesco Tassone22, Mauro Truini23, Liliana Varesco24.   

Abstract

Entities:  

Keywords:  BRCA1; BRCA2; PARP inhibitors; genetic testing; germline mutations; ovarian cancer; somatic mutations

Mesh：

Substances：

Year:  2016        PMID： 27241581     DOI： 10.2217/fon-2016-0189

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  9 in total

1.  Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.

Authors:  Nicoletta Colombo; Gloria Huang; Giovanni Scambia; Eva Chalas; Sandro Pignata; James Fiorica; Linda Van Le; Sharad Ghamande; Santiago González-Santiago; Isabel Bover; Begoña Graña Suárez; Andrew Green; Philippe Huot-Marchand; Yann Bourhis; Sudeep Karve; Christopher Blakeley
Journal:  J Clin Oncol       Date:  2018-03-20       Impact factor: 44.544

2.  Axillary lymph node metastasis in ovarian carcinoma: Two case reports and review of literature.

Authors:  Ram Eitan; Daliah Tsoref; Gad Sabah; Lina Salman
Journal:  Gynecol Oncol Rep       Date:  2017-11-14

3.  Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus.

Authors:  Ettore Capoluongo; Giovanni Scambia; Jean-Marc Nabholtz
Journal:  Oncotarget       Date:  2018-04-13

4.  A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis.

Authors:  Giovanni Luca Scaglione; Paola Concolino; Maria De Bonis; Elisa De Paolis; Angelo Minucci; Gabriella Ferrandina; Giovanni Scambia; Ettore Capoluongo
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

5.  BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories.

Authors:  Ettore Capoluongo; Nicla La Verde; Massimo Barberis; Maria Angela Bella; Fiamma Buttitta; Paola Carrera; Nicoletta Colombo; Laura Cortesi; Massimo Gion; Valentina Guarneri; Domenica Lorusso; Antonio Marchetti; Paolo Marchetti; Nicola Normanno; Barbara Pasini; Matilde Pensabene; Sandro Pignata; Paolo Radice; Enrico Ricevuto; Anna Sapino; Pierosandro Tagliaferri; Pierfrancesco Tassone; Chiara Trevisiol; Mauro Truini; Liliana Varesco; Antonio Russo; Stefania Gori
Journal:  Diagnostics (Basel)       Date:  2019-10-09

6.  Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients.

Authors:  Caterina Fumagalli; Ilaria Betella; Alessandra Rappa; Maria di Giminiani; Michela Gaiano; Luigi Antonio De Vitis; Benedetta Zambetti; Davide Vacirca; Francesco Multinu; Konstantinos Venetis; Nicoletta Colombo; Massimo Barberis; Elena Guerini Rocco
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

7.  An optimized BRCA1/2 next-generation sequencing for different clinical sample types.

Authors:  Yoonjung Kim; Chi Heum Cho; Jung Sook Ha; Do Hoon Kim; Sun Young Kwon; Seoung Chul Oh; Kyung A Lee
Journal:  J Gynecol Oncol       Date:  2019-08-06       Impact factor: 4.401

8.  Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study.

Authors:  Jennifer Foglietta; Vienna Ludovini; Fortunato Bianconi; Lorenza Pistola; Maria Sole Reda; Antonella Al-Refaie; Francesca Romana Tofanetti; Annamaria Mosconi; Elisa Minenza; Paola Anastasi; Carmen Molica; Fabrizio Stracci; Fausto Roila
Journal:  Genes (Basel)       Date:  2020-08-12       Impact factor: 4.096

9.  Longitudinal and multi-tissue molecular diagnostics track somatic BRCA2 reversion mutations that correct the open reading frame of germline alteration upon clinical relapse.

Authors:  Shelly Sorrells; Kelly E McKinnon; Ashleigh McBratney; Christopher Sumey
Journal:  NPJ Genom Med       Date:  2021-02-22       Impact factor: 8.617
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.